The global Gynecomastia Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Gynecomastia Treatment market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology
Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-gynecomastia-treatment-forecast-2023-2030-717
The China market for Global Gynecomastia Treatment market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Gynecomastia Treatment market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Gynecomastia refers to the proliferation of the glandular tissue in the male breast or the enlargement of the male breast. The major cause of gynecomastia is the hormonal imbalance which occurs between the estrogen level and androgen activity amongst the males. Several medications such as anti-androgens, anti-depressants, etc. are also associated with the cause of gynecomastia. Gynecomastia is common in infancy, puberty and middle-aged. The symptoms of gynecomastia include swelling, nipple discharge, pain, etc. Overuse of herbal products such as tea tree or lavender used in shampoo, soaps, and lotions are also associated with gynecomastia. Based on the product type, the Gynecomastia Treatment market has been segmented into drugs and surgeries. The medications used for the treatment of gynecomastia include tamoxifen, Raloxifene, Aromatase Inhibitors, and other medications.
This report aims to provide a comprehensive presentation of the global market for Gynecomastia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gynecomastia Treatment. This report contains market size and forecasts of Gynecomastia Treatment in global, including the following market information:
Global Gynecomastia Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gynecomastia Treatment include Cadila Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Zydus Cadila Healthcare Ltd, Biochem Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Micro Nova Pharmaceuticals Ltd and Kee Pharma Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gynecomastia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gynecomastia Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Gynecomastia Treatment Market Segment Percentages, by Type, 2022 (%)
Drugs
Surgical Treatment
Global Gynecomastia Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Gynecomastia Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Gynecomastia Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Gynecomastia Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
The Middle East and Africa (Middle East, Africa)
South and Central America (Brazil, Argentina, Rest of SCA)
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gynecomastia Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gynecomastia Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cadila Pharmaceuticals Ltd
Sun Pharmaceuticals Industries Ltd
Zydus Cadila Healthcare Ltd
Biochem Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd
Micro Nova Pharmaceuticals Ltd
Kee Pharma Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gynecomastia Treatment, market overview.
Chapter 2: Global Gynecomastia Treatment market size in revenue.
Chapter 3: Detailed analysis of Gynecomastia Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gynecomastia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-gynecomastia-treatment-forecast-2023-2030-717
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :-https://www.linkedin.com/company/24-market-reports
Comments